Do pre-clinical multiple sclerosis models allow us to measure neurodegeneration and clinical progression?

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Expert Review of Neurotherapeutics

• Publication date

  2018-04-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/14737175.2018.1459190PMID 29589965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple sclerosis animal models: a clinical and histopathological perspective

  2017cited by this paper
• Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy.

  2017cited by this paper
• Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression

  2017cited by this paper
• Outcome Measures in Clinical Trials for Multiple Sclerosis

  2017cited by this paper
• Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

  2017cited by this paper
• Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial

  2017cited by this paper
• Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach.

  2016cited by this paper
• Whole-brain ex-vivo quantitative MRI of the cuprizone mouse model

  2016cited by this paper
• Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain

  2016cited by this paper
• Design-Based Stereology for Evaluation of Histological Parameters

  2016cited by this paper
• A comparison of DigiGait™ and TreadScan™ imaging systems: assessment of pain using gait analysis in murine monoarthritis

  2013cited by this paper
• Mitoxantrone for multiple sclerosis.

  2013cited by this paper
• Cortical atrophy in experimental autoimmune encephalomyelitis: In vivo imaging

  2012cited by this paper
• Functional recovery of callosal axons following demyelination: a critical window.

  2009cited by this paper
• Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis

  2009cited by this paper
• Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial

  2007cited by this paper
• Mitoxantrone for multiple sclerosis.

  2005cited by this paper
• Neuroscience and Biobehavioral Reviews Cellular and Molecular Neuropathology of the Cuprizone Mouse Model: Clinical Relevance for Multiple Sclerosis

  year unknowncited by this paper

• Black Seed Oil-Based Curcumin Nanoformulations Ameliorated Cuprizone-Induced Demyelination in the Mouse Hippocampus

  2024cites this paper
• Translational Block in Stroke: A Constructive and “Out-of-the-Box” Reappraisal

  2021cites this paper
• Investigation of neuro-inflammatory parameters in a cuprizone induced mouse model of multiple sclerosis

  2021cites this paper
• Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014–2019

  2020cites this paper
• Aquaporin-4 Expression during Toxic and Autoimmune Demyelination

  2020cites this paper
• Visualization of the Breakdown of the Axonal Transport Machinery: a Comparative Ultrastructural and Immunohistochemical Approach

  2018cites this paper